Previous Close | 25.80 |
Open | 25.65 |
Bid | 25.19 x 800 |
Ask | 26.03 x 1100 |
Day's Range | 25.42 - 25.68 |
52 Week Range | 21.78 - 33.09 |
Volume | |
Avg. Volume | 771,112 |
Market Cap | 11.101B |
Beta (5Y Monthly) | 0.42 |
PE Ratio (TTM) | 50.84 |
EPS (TTM) | 0.50 |
Earnings Date | N/A |
Forward Dividend & Yield | 0.75 (2.91%) |
Ex-Dividend Date | Oct 05, 2023 |
1y Target Est | 34.33 |
Subscribe to Yahoo Finance Plus to view Fair Value for SNN
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
This column broke a few of its own rules when it identified Smith & Nephew, the medical devices company, as a potential post-lockdown turnaround candidate in March 2021 and has only had cause to regret it since.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.